Skip to main content

Bill Belew has raised 2 bi-cultural kids, now 34 and 30. And he and his wife are now parenting a 3rd, Mia, who is 8.




You can’t get that cancer treatment here that is…and here is in the US. But you might be able to get it in China.

Shenzhen’s SiBiono GeneTech Co. produces Gendicine , the world’s first commercially available gene-therapy drug.

They presently have about 70 foreign patients from 22 countries who have sought gene-therapy treatment for a cool $20,000 per two-month course. That’s a lot of yuan. Multiply by 8.

Dr. Li and Dr. Peng are directors and they aim to make their center the leader in the field of gene therapy. They have an edge on us, though Dr. Li studied at John Hopkins U. in the 90’s, because they don’t have the restrictions that the US puts on this kind of research.

China’s State Council is also behind them. Recently 2.5% of gross domestic product was pledged, nearly double what it was before.

China wants to be number one in this field.

But what about the risks?

I heard/read a quote once by one of China’s leaders, “We may lose our people but we will never lose our land.” When land is valued more than people, then where do people rank when it comes to taking the lead in an industry such as this?

Apparently someone/s in China think they might be able to spare a few people to make it to number one.

What do you think?

Talk to Bill and others about their experiences raising bi-cultural Japanese-American kids.

Bill Belew

Daddy and Christian.

Close Menu


Growing Up Aimi Series